As a bit of a background The Australian Red Cross Blood Service (ARCBS) was very much the shopfront for CSL in Australia for the collection of blood ostensibly for the purpose of 'saving lives'. Under early arrangements the ARCBS were paid quite handsomely for the donated blood product, of which a small quantity of that collected being available for transfusion related requirement with the larger portion being sold off as 'Red Gold' to CSL for processing into highly marketable blood products i.e. factor 8 factor 9. The financial process has since changed which has created opacity with respect to financial arrangements between CSL and ARCBS.
With respect to the UK it is blood product that CSL is involved with . CSL Behring (originally formed from the acquisition of Aventis Behring that was then amalgamated with ZLB Bioplasma initially as ZLB Behring and later re branded CSL Behring about 2003/4) Amongst the products used in the UK is product now called 'Voncento', human coag factor 8 which has demand by haemophiliacs.
https://www.cslbehring.co.uk/products/product-range
Quite sadly in Australia many Haemophiliacs and other recipients ended up receiving contaminated blood and blood products as in the UK in the past.
For an interesting perspective on thisAustralian Author Bryce Courtney wrote a book titled 'April fools Day' Bryce's son, a haemophiliac, passed away as a result of contaminated Blood Product
- Forums
- ASX - By Stock
- CSL
- The Great Manipulator
The Great Manipulator, page-108
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$294.13 |
Change
-0.870(0.29%) |
Mkt cap ! $142.4B |
Open | High | Low | Value | Volume |
$295.01 | $296.50 | $293.51 | $164.4M | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 136 | $294.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$294.13 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 136 | 294.100 |
1 | 1274 | 293.860 |
1 | 34 | 293.850 |
1 | 1274 | 293.700 |
1 | 1013 | 293.620 |
Price($) | Vol. | No. |
---|---|---|
294.170 | 949 | 1 |
294.190 | 750 | 1 |
294.240 | 594 | 1 |
294.270 | 46 | 1 |
294.280 | 875 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online